Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 9


Results: 13
    1
    2
    3
    4
    5

    A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.

    Published in:
    Cancer Immunology, Immunotherapy, 2015, v. 64, n. 9, p. 1123, doi. 10.1007/s00262-015-1717-1
    By:
    • Anastasopoulou, Eleftheria;
    • Voutsas, Ioannis;
    • Keramitsoglou, Theodora;
    • Gouttefangeas, Cécile;
    • Kalbacher, Hubert;
    • Thanos, Anastasios;
    • Papamichail, Michael;
    • Perez, Sonia;
    • Baxevanis, Constantin
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    13

    Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.

    Published in:
    Cancer Immunology, Immunotherapy, 2015, v. 64, n. 9, p. 1159, doi. 10.1007/s00262-015-1711-7
    By:
    • Cusi, Maria;
    • Botta, Cirino;
    • Pastina, Pierpaolo;
    • Rossetti, Maria;
    • Dreassi, Elena;
    • Guidelli, Giacomo;
    • Fioravanti, Antonella;
    • Martino, Elodia;
    • Gandolfo, Claudia;
    • Pagliuchi, Marco;
    • Basile, Assunta;
    • Carbone, Salvatore;
    • Ricci, Veronica;
    • Micheli, Lucia;
    • Tassone, Pierfrancesco;
    • Tagliaferri, Pierosandro;
    • Pirtoli, Luigi;
    • Correale, Pierpaolo
    Publication type:
    Article